
KLOW
GHK-Cu + BPC-157 + TB-500 + KPV
KLOW combines GHK-Cu, BPC-157, TB-500 and KPV into a single regenerative blend — the most comprehensive regeneration option available — used across skin remodelling, systemic tissue repair and inflammatory signalling. Typical Course: A full course runs 12 weeks. It begins with a 2-week phase at a lower dose (2mg once daily) so you can assess individual tolerance to the blend, followed by a 10-week phase at 4mg once daily in the morning, when systemic activity is optimal. Most customers notice initial effects around week 2, with results peaking around week 8. What to Expect: Faster recovery, improved skin and collagen quality, reduced inflammation and improved overall tissue health. Key benefits include four compounds in a single formulation, comprehensive regeneration, convenient once-daily administration and synergistic compound action. Considerations & Safety: Because this is a multi-compound blend, individual compound effects cannot be isolated, and sensitivity to one of the components is possible. Common side effects include injection site redness, mild nausea, headache and temporary fatigue. Seek medical attention immediately if you notice signs of infection, severe allergic reaction, persistent worsening symptoms, or high fever.
80 mg
99%+
1,100 AED
| Sequence | Available on request |
| Molecular Formula | Available on request |
| Molecular Weight | Available on request |
| CAS Number | Available on request |
| Form | Reconstituted injection pen |
| Purity | ≥ 99%+ |
Related Compounds

CJC-1295 No DAC + Ipamorelin
GHRH analogue + GH secretagogue blend
Synergistic growth-hormone secretagogue blend.
750 AED

CJC-1295 No DAC
Modified GRF (1-29)
GHRH analogue for pulsatile GH-release support.
850 AED

Ipamorelin
Selective growth-hormone secretagogue.
850 AED

GLOW
GHK-Cu + BPC-157 + TB-500
Skin, healing & recovery tri-blend.
750 AED